Sense Biodetection Ltd.

📍 Oxford, United Kingdom🗓 Founded 2014👥 47 employees💰 Last funded Jul 2019
Sense is transforming healthcare by redefining diagnostics. Founded in 2014, we strive to improve lives by bringing powerful tools for fast, accurate, and accessible diagnostics to all. We’re focused on creating a portfolio of unconstrained, instrument-free molecular diagnostic technologies. Our Veros™ platform introduces novel and proprietary rapid molecular amplification technology to detect a variety of deadly and costly diseases. We’re developing technologies that combine the power of laboratory tests with the simplicity and ease of use of products because we believe that if you can test anywhere, you can change everything.* *Professional use, patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
4
Total investors
1
Early stage
3
Mid stage
0
Late stage
2014
Founded
Investor geography2 countries
United Kingdom
2
Germany
1
Investor activity2016–2019 · investors recorded per year
2016120193
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Sense Biodetection Ltd.?
Sense Biodetection Ltd. has 4 investors on record on gritt.io, including 1 early-stage backers, 3 mid-stage.
When did Sense Biodetection Ltd. last raise funding?
The most recent investment in Sense Biodetection Ltd. recorded on gritt.io was in July 2019.
When was Sense Biodetection Ltd. founded?
Sense Biodetection Ltd. was founded in 2014.
What industry is Sense Biodetection Ltd. in?
Sense Biodetection Ltd. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Sense Biodetection Ltd. based?
Sense Biodetection Ltd. is headquartered in Oxford, United Kingdom.